Video Gallery
Redefining Imaging Workflows in Clinical Trials | Full Interview
At the Veeva R&D and Quality Summit in Boston, Moe Alsumidaie interviewed Jeff Sorenson, CEO of Yunu, and Steve Tolle, Chief Product & Technology Officer at Ignitedata, on how the updated ICH E6(R3) guidance is transforming imaging in clinical trials.
Redefining Clinical Imaging: How a Site-First Approach is Setting a New Standard for Transparency & Data Integrity | Full Interview
Redefining Clinical Imaging: Error Rates in Imaging Assessments | Patrick McNamara | Part 1
Redefining Clinical Imaging: Real-Time Access to Source Imaging Data|Patrick McNamara|Part 2
Yunu provides real-time access to source imaging data and helps rebuild the trust between sites and sponsors.
Redefining Clinical Imaging: Are your trials built to pass audit? |Patrick McNamara|Part 3
As Patrick McNamara shared, the center’s success came from using a fully traceable and transparent platform, where every imaging time point, every process, and every audit trail was digital and verifiable. The result? Total confidence — not just in compliance, but in data credibility.
Redefining Clinical Imaging: Bottlenecks in Imaging-Based Trials|Patrick McNamara|Part 4
Redefining Clinical Imaging: Delays in Imaging|Patrick McNamara|Part 5
Delays in imaging are not just operational challenges. They directly impact whether patients remain eligible for life saving trials. Hear from Yunu CCO, Patrick McNamara as he highlights why faster, connected imaging workflows are essential to protecting patient access and why the industry can no longer accept delays as normal.
Imaging as Infrastructure: Why Sponsors Must Rethink Oversight in Modern Trials | Full Interview
At DPHARM, Paul McCracken, Founder and Principal of RadiaNova Consulting, sheds light on the hidden challenges of clinical trial imaging and how radiopharmaceutical studies are transforming its role.
Imaging as Infrastructure: Interview Part 5
Imaging as Infrastructure: Interview Part 4
Imaging as Infrastructure: Interview Part 3
Imaging as Infrastructure: Interview Part 2
Imaging as Infrastructure: Interview Part 1
The Hidden Cost of Imaging Error in Oncology Trials
When the Best Sites Still Get It Wrong
When Pharma Makes Decisions on Flawed Imaging Data
The Workflow Maze Behind Imaging Friction
The Black Box Between Site & Sponsor
The Ten Percent Washout We Accept
Building the Highway for Frictionless Imaging
Imaging Steps into GCP Oversight
Standardizing Imaging at the Site Level
From Friction to Framework
Connectivity Is the Future of Trial Imaging
The Imaging Source of Truth for Transparent, Compliant, and Efficient Clinical Trials
Yunu Full City of Hope Panel
June 2025
JPM 2024 - Imaging Wire Interview
What challenges are faced by imaging providers that want to participate in oncology clinical trials? Hear about the problems -- and solutions -- with Yunu co-founders Jeffrey Sorenson and Gordon Harris during this interview with The Imaging Wire's Brian Casey at the JP Morgan Health Care Conference and Biotech Showcase.

